Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of an investigational hormone preparation versus liraglutide in Japan
jRCT2080224708Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2019
- Modality
- Peptides
01
Overview
Phase 2 trial of liraglutide (2 arms), sponsored by Novo Nordisk. Started Jun 2019; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080224708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224708.